In the latest session, Revolution Medicines Inc (NASDAQ: RVMD) closed at $30.14 down -3.98% from its previous closing price of $31.39. In other words, the price has decreased by -$1.25 from its previous closing price. On the day, 1077585 shares were traded.
Ratios:
For a deeper understanding of Revolution Medicines Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.06 and its Current Ratio is at 13.06. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on March 11, 2024, initiated with a Overweight rating and assigned the stock a target price of $43.
On January 05, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $31 to $34.
On January 04, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $41.Wedbush initiated its Outperform rating on January 04, 2024, with a $41 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 27 ’24 when Cislini Jeff sold 1,500 shares for $30.99 per share. The transaction valued at 46,481 led to the insider holds 54,374 shares of the business.
GOLDSMITH MARK A sold 5,788 shares of RVMD for $182,804 on Mar 18 ’24. The insider now owns 460,379 shares after completing the transaction at $31.58 per share. On Mar 18 ’24, another insider, Horn Margaret A, who serves as the Chief Operating Officer of the company, sold 2,914 shares for $31.58 each. As a result, the insider received 92,033 and left with 139,553 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVMD now has a Market Capitalization of 4.96B and an Enterprise Value of 3.20B. For the stock, the TTM Price-to-Sale (P/S) ratio is 428.65 while its Price-to-Book (P/B) ratio in mrq is 2.72. Its current Enterprise Value per Revenue stands at 276.23 whereas that against EBITDA is -7.43.
Stock Price History:
Over the past 52 weeks, RVMD has reached a high of $35.60, while it has fallen to a 52-week low of $15.44. The 50-Day Moving Average of the stock is 30.22, while the 200-Day Moving Average is calculated to be 27.71.
Shares Statistics:
For the past three months, RVMD has traded an average of 1.36M shares per day and 1.14M over the past ten days. A total of 164.67M shares are outstanding, with a floating share count of 136.41M. Insiders hold about 17.17% of the company’s shares, while institutions hold 78.97% stake in the company. Shares short for RVMD as of Mar 15, 2024 were 16.4M with a Short Ratio of 12.08, compared to 16.96M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.96% and a Short% of Float of 10.34%.
Earnings Estimates
There are 10 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.74 for the current quarter, with a high estimate of -$0.67 and a low estimate of -$0.85, while EPS last year was -$0.72. The consensus estimate for the next quarter is -$0.77, with high estimates of -$0.7 and low estimates of -$0.86.
Analysts are recommending an EPS of between -$2.99 and -$3.53 for the fiscal current year, implying an average EPS of -$3.18. EPS for the following year is -$3.47, with 10 analysts recommending between -$2.85 and -$4.02.
